_id
69185d973c536f8df2317d40
Ticker
0QQO.LSE
Name
Siegfried Holding AG
Exchange
LSE
Address
Untere Bruehlstrasse 4, Zofingen, Switzerland, 4800
Country
UK
Sector
Industry
Currency
GBP
Website
https://www.siegfried.ch
Description
Siegfried Holding AG, together with its subsidiaries, engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide. The company offers drug substances, including exclusive synthesis that manufactures custom APIs. It also offers an API portfolio, including non-exclusive APIs and pharma-grade substances that focus on anesthetics, pain and addiction treatment applications, and central nervous and respiratory diseases, as well as caffeine for human health and nutrition. In addition, the company offers drug products, including steriles, which includes fill and finish in vials, ampoules, cartridges, and pre-filled syringes; ophthalmics, such as sterile ointments, gels, and suspensions and solutions; inhalation products, including capsules in medical devices for inhalation applications; oral solid dosage forms, which includes tablets and capsules; and viral vectors, such as AAV and lentiviruses for gene therapy. Further, it provides technologies with chemistry capabilities, analytical services, formulation technologies, bridging technologies, containment technology, and cell and gene therapies. The company was founded in 1873 and is headquartered in Zofingen, Switzerland.
Last Close
69.98527174806
Volume
1671
Current Price
75.3
Change
-0.11056218848238251
Last Updated
2025-12-29T14:39:04.770Z
Image
https://logo.clearbit.com/www.siegfried.ch
Ipo Date
-
Market Cap
307140576
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
619517000
Cost Of Revenue
456539000
Gross Profit
162978000
Operating Expenses
77489000
Operating Income
85489000
Interest Expense
3689000
Pretax Income
81219000
Net Income
65396000
Eps
1.4900000300752345
Dividends Per Share
16633000
Shares Outstanding
4161420
Income Tax Expense
15950000
EBITDA
128840000
Operating Margin
13.79929848575584
Total Other Income Expense Net
-4270000
Cash
34489000
Short Term Investments
860000
Receivables
317045000
Inventories
471535000
Total Current Assets
942274000
Property Plant Equipment
943406000
Total Assets
1971691000
Payables
99807000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
949218000
Equity
1022884000
Bs_currency_symbol
-
Depreciation
43932000
Change In Working Capital
-5824000
Cash From Operations
145899000
Capital Expenditures
101479000
Cash From Investing
-109165000
Cash From Financing
-40193000
Net Change In Cash
-4267000
Cf_currency_symbol
-
PE
0.0335
PB
3.230974264530484
ROE
6.3932958184896815
ROA
3.3167468939098472
FCF
44420000
Fcf Percent
0.07170101869682349
Piotroski FScore
4
Health Score
56
Deep Value Investing Score
7
Defensive Investing Score
7.5
Dividend Investing Score
3.5
Economic Moat Investing Score
7.8
Garp Investing Score
3.5
Growth Investing Score
3
Momentum Investing Score
4.5
Net Net Investing Score
4
Quality Investing Score
6.5
Value Investing Score
8
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
619517000
Quarters > 0 > income Statement > cost Of Revenue
456539000
Quarters > 0 > income Statement > gross Profit
162978000
Quarters > 0 > income Statement > operating Expenses
77489000
Quarters > 0 > income Statement > operating Income
85489000
Quarters > 0 > income Statement > interest Expense
3689000
Quarters > 0 > income Statement > pretax Income
81219000
Quarters > 0 > income Statement > net Income
65396000
Quarters > 0 > income Statement > eps
1.4900000300752345
Quarters > 0 > income Statement > dividends Per Share
16633000
Quarters > 0 > income Statement > shares Outstanding
43889932
Quarters > 0 > income Statement > income Tax Expense
15950000
Quarters > 0 > income Statement > EBITDA
128840000
Quarters > 0 > income Statement > operating Margin
13.79929848575584
Quarters > 0 > income Statement > total Other Income Expense Net
-4270000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
34489000
Quarters > 0 > balance Sheet > short Term Investments
860000
Quarters > 0 > balance Sheet > receivables
317045000
Quarters > 0 > balance Sheet > inventories
471535000
Quarters > 0 > balance Sheet > total Current Assets
942274000
Quarters > 0 > balance Sheet > property Plant Equipment
943406000
Quarters > 0 > balance Sheet > total Assets
1971691000
Quarters > 0 > balance Sheet > payables
99807000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
949218000
Quarters > 0 > balance Sheet > equity
1022884000
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
65396000
Quarters > 0 > cash Flow > depreciation
43932000
Quarters > 0 > cash Flow > change In Working Capital
-5824000
Quarters > 0 > cash Flow > cash From Operations
145899000
Quarters > 0 > cash Flow > capital Expenditures
101479000
Quarters > 0 > cash Flow > cash From Investing
-109165000
Quarters > 0 > cash Flow > cash From Financing
-40193000
Quarters > 0 > cash Flow > net Change In Cash
-4267000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
1.4900000300752345
Quarters > 0 > ratios > PB
3.230974264530484
Quarters > 0 > ratios > ROE
6.3932958184896815
Quarters > 0 > ratios > ROA
3.3167468939098472
Quarters > 0 > ratios > FCF
44420000
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
0.07170101869682349
Quarters > 0 > health Score
56
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
674669000
Quarters > 1 > income Statement > cost Of Revenue
505134000
Quarters > 1 > income Statement > gross Profit
169535000
Quarters > 1 > income Statement > operating Expenses
58133000
Quarters > 1 > income Statement > operating Income
111402000
Quarters > 1 > income Statement > interest Expense
3740000
Quarters > 1 > income Statement > pretax Income
106265000
Quarters > 1 > income Statement > net Income
88681000
Quarters > 1 > income Statement > eps
2.043051973753022
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
43406140
Quarters > 1 > income Statement > income Tax Expense
17653000
Quarters > 1 > income Statement > EBITDA
158792000
Quarters > 1 > income Statement > operating Margin
16.51209704314264
Quarters > 1 > income Statement > total Other Income Expense Net
-5137000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
38756000
Quarters > 1 > balance Sheet > short Term Investments
856000
Quarters > 1 > balance Sheet > receivables
411395000
Quarters > 1 > balance Sheet > inventories
387580000
Quarters > 1 > balance Sheet > total Current Assets
939375000
Quarters > 1 > balance Sheet > property Plant Equipment
909988000
Quarters > 1 > balance Sheet > total Assets
1933722000
Quarters > 1 > balance Sheet > payables
95505000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
953814000
Quarters > 1 > balance Sheet > equity
980192000
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
88507000
Quarters > 1 > cash Flow > depreciation
41882000
Quarters > 1 > cash Flow > change In Working Capital
-35294000
Quarters > 1 > cash Flow > cash From Operations
49849000
Quarters > 1 > cash Flow > capital Expenditures
118452000
Quarters > 1 > cash Flow > cash From Investing
-123927000
Quarters > 1 > cash Flow > cash From Financing
47706000
Quarters > 1 > cash Flow > net Change In Cash
-25702000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
2.043051973753022
Quarters > 1 > ratios > PB
3.334532767049721
Quarters > 1 > ratios > ROE
9.047309098625576
Quarters > 1 > ratios > ROA
4.586026326431617
Quarters > 1 > ratios > FCF
-68603000
Quarters > 1 > ratios > Piotroski FScore
3
Quarters > 1 > ratios > fcf Percent
-0.10168393686385473
Quarters > 1 > health Score
53
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
619904000
Quarters > 2 > income Statement > cost Of Revenue
460382000
Quarters > 2 > income Statement > gross Profit
159522000
Quarters > 2 > income Statement > operating Expenses
71664000
Quarters > 2 > income Statement > operating Income
87858000
Quarters > 2 > income Statement > interest Expense
4788000
Quarters > 2 > income Statement > pretax Income
90003000
Quarters > 2 > income Statement > net Income
71383000
Quarters > 2 > income Statement > eps
1.6580003516541097
Quarters > 2 > income Statement > dividends Per Share
15386000
Quarters > 2 > income Statement > shares Outstanding
43053670
Quarters > 2 > income Statement > income Tax Expense
18726000
Quarters > 2 > income Statement > EBITDA
130702000
Quarters > 2 > income Statement > operating Margin
14.172839665496593
Quarters > 2 > income Statement > total Other Income Expense Net
2145000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
64458000
Quarters > 2 > balance Sheet > short Term Investments
410000
Quarters > 2 > balance Sheet > receivables
308515000
Quarters > 2 > balance Sheet > inventories
464804000
Quarters > 2 > balance Sheet > total Current Assets
964278000
Quarters > 2 > balance Sheet > property Plant Equipment
833737000
Quarters > 2 > balance Sheet > total Assets
1877780000
Quarters > 2 > balance Sheet > payables
91110000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
971245000
Quarters > 2 > balance Sheet > equity
866738000
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
71383000
Quarters > 2 > cash Flow > depreciation
42844000
Quarters > 2 > cash Flow > change In Working Capital
26932000
Quarters > 2 > cash Flow > cash From Operations
118928000
Quarters > 2 > cash Flow > capital Expenditures
62395000
Quarters > 2 > cash Flow > cash From Investing
-66419000
Quarters > 2 > cash Flow > cash From Financing
-44667000
Quarters > 2 > cash Flow > net Change In Cash
64458000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
1.6580003516541097
Quarters > 2 > ratios > PB
3.7403936956727404
Quarters > 2 > ratios > ROE
8.235822128486348
Quarters > 2 > ratios > ROA
3.801457039695811
Quarters > 2 > ratios > FCF
56533000
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.09119637879413586
Quarters > 2 > health Score
54
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
664442000
Quarters > 3 > income Statement > cost Of Revenue
491719000
Quarters > 3 > income Statement > gross Profit
172723000
Quarters > 3 > income Statement > operating Expenses
80993000
Quarters > 3 > income Statement > operating Income
91730000
Quarters > 3 > income Statement > interest Expense
5193000
Quarters > 3 > income Statement > pretax Income
75520000
Quarters > 3 > income Statement > net Income
57559000
Quarters > 3 > income Statement > eps
1.323438793341304
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
43492000
Quarters > 3 > income Statement > income Tax Expense
18034000
Quarters > 3 > income Statement > EBITDA
136250000
Quarters > 3 > income Statement > operating Margin
13.805569184368235
Quarters > 3 > income Statement > total Other Income Expense Net
-16210000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
56363000
Quarters > 3 > balance Sheet > short Term Investments
263000
Quarters > 3 > balance Sheet > receivables
433391000
Quarters > 3 > balance Sheet > inventories
431938000
Quarters > 3 > balance Sheet > total Current Assets
983164000
Quarters > 3 > balance Sheet > property Plant Equipment
801072000
Quarters > 3 > balance Sheet > total Assets
1861505000
Quarters > 3 > balance Sheet > payables
98848000
Quarters > 3 > balance Sheet > short Term Debt
-46802000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
1023371000
Quarters > 3 > balance Sheet > equity
838237000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
57559000
Quarters > 3 > cash Flow > depreciation
42817000
Quarters > 3 > cash Flow > change In Working Capital
121000
Quarters > 3 > cash Flow > cash From Operations
125145000
Quarters > 3 > cash Flow > capital Expenditures
72562000
Quarters > 3 > cash Flow > cash From Investing
-72281000
Quarters > 3 > cash Flow > cash From Financing
-25473000
Quarters > 3 > cash Flow > net Change In Cash
25912000
Quarters > 3 > cash Flow > currency_symbol
GBP
Quarters > 3 > ratios > PE
1.323438793341304
Quarters > 3 > ratios > PB
3.9069470805989233
Quarters > 3 > ratios > ROE
6.866673745014834
Quarters > 3 > ratios > ROA
3.0920679772549633
Quarters > 3 > ratios > FCF
52583000
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
0.07913858545967895
Quarters > 3 > health Score
51
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
1294573000
Annuals > 0 > income Statement > cost Of Revenue
965516000
Annuals > 0 > income Statement > gross Profit
329057000
Annuals > 0 > income Statement > operating Expenses
129797000
Annuals > 0 > income Statement > operating Income
199260000
Annuals > 0 > income Statement > interest Expense
8528000
Annuals > 0 > income Statement > pretax Income
196268000
Annuals > 0 > income Statement > net Income
160064000
Annuals > 0 > income Statement > eps
3.687588898713408
Annuals > 0 > income Statement > dividends Per Share
15386000
Annuals > 0 > income Statement > shares Outstanding
43406140
Annuals > 0 > income Statement > income Tax Expense
36379000
Annuals > 0 > income Statement > EBITDA
289494000
Annuals > 0 > income Statement > operating Margin
15.391947769650688
Annuals > 0 > income Statement > total Other Income Expense Net
-2992000
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
38756000
Annuals > 0 > balance Sheet > short Term Investments
856000
Annuals > 0 > balance Sheet > receivables
411395000
Annuals > 0 > balance Sheet > inventories
387580000
Annuals > 0 > balance Sheet > total Current Assets
939375000
Annuals > 0 > balance Sheet > property Plant Equipment
909988000
Annuals > 0 > balance Sheet > total Assets
1933722000
Annuals > 0 > balance Sheet > payables
95505000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
953814000
Annuals > 0 > balance Sheet > equity
980192000
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
159890000
Annuals > 0 > cash Flow > depreciation
84726000
Annuals > 0 > cash Flow > change In Working Capital
-8362000
Annuals > 0 > cash Flow > cash From Operations
168777000
Annuals > 0 > cash Flow > capital Expenditures
180847000
Annuals > 0 > cash Flow > cash From Investing
-190346000
Annuals > 0 > cash Flow > cash From Financing
3039000
Annuals > 0 > cash Flow > net Change In Cash
-17607000
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
3.687588898713408
Annuals > 0 > ratios > PB
3.2991061241062978
Annuals > 0 > ratios > ROE
16.329861904606442
Annuals > 0 > ratios > ROA
8.277508349183595
Annuals > 0 > ratios > FCF
-12070000
Annuals > 0 > ratios > Piotroski FScore
4
Annuals > 0 > ratios > fcf Percent
-0.009323537567985738
Annuals > 0 > health Score
63
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
1271494000
Annuals > 1 > income Statement > cost Of Revenue
951086000
Annuals > 1 > income Statement > gross Profit
320408000
Annuals > 1 > income Statement > operating Expenses
148340000
Annuals > 1 > income Statement > operating Income
172068000
Annuals > 1 > income Statement > interest Expense
9289000
Annuals > 1 > income Statement > pretax Income
150376000
Annuals > 1 > income Statement > net Income
112774000
Annuals > 1 > income Statement > eps
2.622461491738621
Annuals > 1 > income Statement > dividends Per Share
14438000
Annuals > 1 > income Statement > shares Outstanding
43003110
Annuals > 1 > income Statement > income Tax Expense
37682000
Annuals > 1 > income Statement > EBITDA
241218000
Annuals > 1 > income Statement > operating Margin
13.532741798231058
Annuals > 1 > income Statement > total Other Income Expense Net
-21692000
Annuals > 1 > income Statement > currency_symbol
-
Annuals > 1 > balance Sheet > cash
56363000
Annuals > 1 > balance Sheet > short Term Investments
263000
Annuals > 1 > balance Sheet > receivables
408735000
Annuals > 1 > balance Sheet > inventories
431938000
Annuals > 1 > balance Sheet > total Current Assets
983164000
Annuals > 1 > balance Sheet > property Plant Equipment
801070000
Annuals > 1 > balance Sheet > total Assets
1861505000
Annuals > 1 > balance Sheet > payables
98848000
Annuals > 1 > balance Sheet > short Term Debt
-46802000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
1023372000
Annuals > 1 > balance Sheet > equity
838237000
Annuals > 1 > balance Sheet > currency_symbol
-
Annuals > 1 > cash Flow > net Income
112693000
Annuals > 1 > cash Flow > depreciation
81353000
Annuals > 1 > cash Flow > change In Working Capital
-21593000
Annuals > 1 > cash Flow > cash From Operations
208608000
Annuals > 1 > cash Flow > capital Expenditures
137094000
Annuals > 1 > cash Flow > cash From Investing
-146864000
Annuals > 1 > cash Flow > cash From Financing
-94750000
Annuals > 1 > cash Flow > net Change In Cash
-35120000
Annuals > 1 > cash Flow > currency_symbol
GBP
Annuals > 1 > ratios > PE
2.622461491738621
Annuals > 1 > ratios > PB
3.8219879282350937
Annuals > 1 > ratios > ROE
13.453712971391147
Annuals > 1 > ratios > ROA
6.05821633570686
Annuals > 1 > ratios > FCF
71514000
Annuals > 1 > ratios > Piotroski FScore
4
Annuals > 1 > ratios > fcf Percent
0.05624407193427574
Annuals > 1 > health Score
56
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
1229518000
Annuals > 2 > income Statement > cost Of Revenue
910828000
Annuals > 2 > income Statement > gross Profit
318690000
Annuals > 2 > income Statement > operating Expenses
91072000
Annuals > 2 > income Statement > operating Income
227618000
Annuals > 2 > income Statement > interest Expense
7574000
Annuals > 2 > income Statement > pretax Income
218774000
Annuals > 2 > income Statement > net Income
156490000
Annuals > 2 > income Statement > eps
3.6279830185634774
Annuals > 2 > income Statement > dividends Per Share
13535000
Annuals > 2 > income Statement > shares Outstanding
43134160
Annuals > 2 > income Statement > income Tax Expense
62284000
Annuals > 2 > income Statement > EBITDA
308296000
Annuals > 2 > income Statement > operating Margin
18.51278305807642
Annuals > 2 > income Statement > total Other Income Expense Net
-8844000
Annuals > 2 > income Statement > currency_symbol
GBP
Annuals > 2 > balance Sheet > cash
91483000
Annuals > 2 > balance Sheet > short Term Investments
135000
Annuals > 2 > balance Sheet > receivables
423092000
Annuals > 2 > balance Sheet > inventories
405782000
Annuals > 2 > balance Sheet > total Current Assets
944887000
Annuals > 2 > balance Sheet > property Plant Equipment
779901000
Annuals > 2 > balance Sheet > total Assets
1793200000
Annuals > 2 > balance Sheet > payables
114065000
Annuals > 2 > balance Sheet > short Term Debt
-7600000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
1082272000
Annuals > 2 > balance Sheet > equity
710928000
Annuals > 2 > balance Sheet > currency_symbol
GBP
Annuals > 2 > cash Flow > net Income
156490000
Annuals > 2 > cash Flow > depreciation
80899000
Annuals > 2 > cash Flow > change In Working Capital
-124285000
Annuals > 2 > cash Flow > cash From Operations
142340000
Annuals > 2 > cash Flow > capital Expenditures
103585000
Annuals > 2 > cash Flow > cash From Investing
-103655000
Annuals > 2 > cash Flow > cash From Financing
-18578000
Annuals > 2 > cash Flow > net Change In Cash
18862000
Annuals > 2 > cash Flow > currency_symbol
GBP
Annuals > 2 > ratios > PE
3.6279830185634774
Annuals > 2 > ratios > PB
4.5201411676006575
Annuals > 2 > ratios > ROE
22.01207435914748
Annuals > 2 > ratios > ROA
8.726857015391479
Annuals > 2 > ratios > FCF
38755000
Annuals > 2 > ratios > Piotroski FScore
3
Annuals > 2 > ratios > fcf Percent
0.03152048201002344
Annuals > 2 > health Score
60
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
1102423000
Annuals > 3 > income Statement > cost Of Revenue
863153000
Annuals > 3 > income Statement > gross Profit
239270000
Annuals > 3 > income Statement > operating Expenses
109240000
Annuals > 3 > income Statement > operating Income
130030000
Annuals > 3 > income Statement > interest Expense
3861000
Annuals > 3 > income Statement > pretax Income
126562000
Annuals > 3 > income Statement > net Income
95600000
Annuals > 3 > income Statement > eps
2.202717268335663
Annuals > 3 > income Statement > dividends Per Share
12630000
Annuals > 3 > income Statement > shares Outstanding
43400940
Annuals > 3 > income Statement > income Tax Expense
30927000
Annuals > 3 > income Statement > EBITDA
213539000
Annuals > 3 > income Statement > operating Margin
11.794928081144898
Annuals > 3 > income Statement > total Other Income Expense Net
-3503000
Annuals > 3 > income Statement > currency_symbol
GBP
Annuals > 3 > balance Sheet > cash
72621000
Annuals > 3 > balance Sheet > short Term Investments
345000
Annuals > 3 > balance Sheet > receivables
363701000
Annuals > 3 > balance Sheet > inventories
364656000
Annuals > 3 > balance Sheet > total Current Assets
826166000
Annuals > 3 > balance Sheet > property Plant Equipment
789321000
Annuals > 3 > balance Sheet > total Assets
1669158000
Annuals > 3 > balance Sheet > payables
119932000
Annuals > 3 > balance Sheet > short Term Debt
-32571000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
1060941000
Annuals > 3 > balance Sheet > equity
608217000
Annuals > 3 > balance Sheet > currency_symbol
GBP
Annuals > 3 > cash Flow > net Income
95600000
Annuals > 3 > cash Flow > depreciation
81891000
Annuals > 3 > cash Flow > change In Working Capital
-52072000
Annuals > 3 > cash Flow > cash From Operations
119749000
Annuals > 3 > cash Flow > capital Expenditures
113100000
Annuals > 3 > cash Flow > cash From Investing
-250013000
Annuals > 3 > cash Flow > cash From Financing
148763000
Annuals > 3 > cash Flow > net Change In Cash
18208000
Annuals > 3 > cash Flow > currency_symbol
GBP
Annuals > 3 > ratios > PE
2.202717268335663
Annuals > 3 > ratios > PB
5.316145438223528
Annuals > 3 > ratios > ROE
15.718074305716545
Annuals > 3 > ratios > ROA
5.727438624743733
Annuals > 3 > ratios > FCF
6649000
Annuals > 3 > ratios > Piotroski FScore
3
Annuals > 3 > ratios > fcf Percent
0.006031260233141
Annuals > 3 > health Score
51
Valuation > metrics > PE
0.0335
Valuation > metrics > PB
3.230974264530484
Valuation > final Score
67.69025735469516
Valuation > verdict
46.0% Undervalued
Profitability > metrics > ROE
6.3932958184896815
Profitability > metrics > ROA
6.940231822166377
Profitability > metrics > Net Margin
0.10555965373024469
Profitability > final Score
49
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.9279820585716464
Risk > metrics > Interest Coverage
23.174030902683654
Risk > final Score
88
Risk > verdict
Low
Liquidity > metrics > Current Ratio
9.440961054835833
Liquidity > metrics > Quick Ratio
4.716492831164147
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
66.65467232950279
Prev Valuations > 1
62.59606304327259
Prev Valuations > 2
60.93052919401077
Prev Profitabilities > 0
66
Prev Profitabilities > 1
56
Prev Profitabilities > 2
44
Prev Risks > 0
88
Prev Risks > 1
70
Prev Risks > 2
70
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:57:51.004Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-20
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Siegfried Holding AG, together with its subsidiaries, engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide. The company offers drug substances, including exclusive synthesis that manufactures custom APIs. It also offers an API portfolio, including non-exclusive APIs and pharma-grade substances that focus on anesthetics, pain and addiction treatment applications, and central nervous and respiratory diseases, as well as caffeine for human health and nutrition. In addition, the company offers drug products, including steriles, which includes fill and finish in vials, ampoules, cartridges, and pre-filled syringes; ophthalmics, such as sterile ointments, gels, and suspensions and solutions; inhalation products, including capsules in medical devices for inhalation applications; oral solid dosage forms, which includes tablets and capsules; and viral vectors, such as AAV and lentiviruses for gene therapy. Further, it provides technologies with chemistry capabilities, analytical services, formulation technologies, bridging technologies, containment technology, and cell and gene therapies. The company was founded in 1873 and is headquartered in Zofingen, Switzerland.
Stock Price
£0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-06-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Siegfried Holding AG
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
—
EPS Actual
—
EPS Estimate
—
EPS Difference
—
Surprise Percent
undefined%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
£ 0
Cost Of Revenue
£ 0
Gross Profit
£ 0
Operating Expenses
£ 0
Operating Income
£ 0
Interest Expense
£ 0
Pretax Income
£ 0
Net Income
£ 0
Income Tax Expense
£ 0
EBITDA
£ 0
Total Other Income Expense Net
£ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
£ 0
Short Term Investments
£ 0
Receivables
£ 0
Inventories
£ 0
Total Current Assets
£ 0
Property Plant Equipment
£ 0
Total Assets
£ 0
Payables
£ 0
Short Term Debt
£ 0
Long Term Debt
£ 0
Total Liabilities
£ 0
Equity
£ 0
(Last Updated 2025-06-30)
Net Income
£ 0
Depreciation
£ 0
Change In Working Capital
£ 0
Cash From Operations
£ 0
Capital Expenditures
£ 0
Cash From Investing
£ 0
Cash From Financing
£ 0
Net Change In Cash
£ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.